Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...
AI scaling is hindered by fragmented enterprise infrastructure in a constantly shifting technology ecosystem. A new ...
Like all AI models based on the Transformer architecture, the large language models (LLMs) that underpin today’s coding ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Jan. 21, 2026 A major global study suggests that a hidden mismatch between two common blood tests could quietly signal serious trouble ahead. When results from creatinine and cystatin C—two markers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback